|
Orthologous residues
|
|
eNOS (human): S1177‑p, eNOS (mouse): S1176‑p, eNOS (rat): S1176‑p, eNOS (rabbit): S1183‑p, eNOS (pig): S1179‑p, eNOS (cow): S1179‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
heart
|
|
Cellular systems studied:
tissue
|
|
Species studied:
rat
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
bradykinin
|
|
|
|
increase
|
|
|
insulin
|
|
|
|
increase
|
|
|
ischemia
|
|
|
|
increase
|
|
|
bradykinin
|
ischemia
|
|
|
augment treatment-induced increase
|
|
|
insulin
|
ischemia
|
|
|
augment treatment-induced increase
|
|
|
LY294002
|
ischemia
|
|
|
inhibit treatment-induced increase
|
|
|
